In this study, we demonstrate that MCP-1 promotes VEGF-A expression in OSCC by activating integrin-linked kinase (ILK) and MEK1/2 signaling and downregulating miR-29c expression, all of which subsequently enhances VEGF-A-induced tumor angiogenesis. This evidence concerns the gene ILK and neoplasm.